(2019, PMID 30915550) , and it is worth noting that essentially all of that evidence is preclinical our breakdown of BPC-157's FDA approval status and the parallel TB-500 regulatory picture cover why neither compound has cleared the approval pathway
Examples of peptide compounds within WADAs regulatory framework are summarized in Tables 1 and 2, which distinguish between non-prohibited peptides and peptide hormones, growth factors, and related substances that are prohibited
[27] In pediatric cryptorchidism, dosing may range from 500 IU three times weekly for 3 weeks to 4,000 IU three times weekly for 6 weeks, based on clinical protocol
Shop Shop on Peptides Clinic
This range translates to approximately 1.6 to 4.0 micrograms per kilogram of body weight when scaled from effective animal doses
This isn't arbitrary it's based on Khavinson's bioregulation framework and the protocols from the original St